Clinical trial No longer in our active list Interventional Ages 18 and up

Laser treatment for anal fistulas

Official title: LATFIA-trial: Laser Assisted Treatment of Fistula In Ano Randomized Controlled Trial Comparing FiLaCTM to Rectal Advancement Flap

Run by University Hospital, Antwerp · NCT05390151 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a new laser treatment for anal fistulas works better than the traditional surgery method for people who have been dealing with this condition.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment176 (estimated)
SponsorUniversity Hospital, Antwerp
Academic / other
Locations5 sites (Edegem, Antwerpen and 4 other locations)
Trial IDNCT05390151 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a single, continuous high transsphincteric fistula that has been managed with a loose seton for at least two months.

Probably not a fit

Patients with complex fistula systems, inflammatory bowel disease, or other specified exclusions will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares the effectiveness of laser-assisted closure of high transsphincteric fistulas to the traditional rectal advancement flap method. Participants will have a single, continuous fistula that has been treated with a loose seton for at least two months and will undergo MRI mapping. The laser technique uses a radial-emitting fiber to destroy the fistula tissue without damaging the surrounding sphincter muscles, while the rectal advancement flap involves excising the fistula and using surrounding tissue to close the defect. The goal is to determine which method provides better outcomes for patients with this complex condition.

Why it matters

Potential benefit: If successful, this treatment could offer a less invasive option for patients with high transsphincteric fistulas, potentially reducing recovery time and complications.

How similar studies have gone: While laser-assisted techniques are gaining interest, this specific comparison with the rectal advancement flap is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with fistula involving more than one-third of the external anal sphincter
* Single, continuous fistula tract at time of inclusion
* Loose seton present in fistula tract for 2 months or more at time of inclusion
* Age ≥ 18
* Able to complete an informed written consent, understand its implications and contents, and participate in follow-up

Exclusion Criteria:

* Fistula tract \< 1 cm
* Complex fistula tract system (branching of fistula tract inside the sphincter complex)
* Pregnancy
* HIV-positive
* Crohn´s disease, Ulcerative colitis
* Fistula due to malignancy
* Tuberculosis
* Hidradenitis Suppurativa
* No internal opening
* Unable to undergo or contraindications to MRI

Where it's running

  • Antwerp University Hospital
    Edegem, Antwerpen, Belgium
    Recruiting
  • Az St Dimpna Geel
    Geel, Antwerpen, Belgium
    Recruiting
  • Jessa Ziekenhuis Hasselt
    Hasselt, Limburg, Belgium
    Recruiting
  • Gent University Hospital
    Gent, Oost- Vlaanderen, Belgium
    Not yet recruiting
  • Brussels University Hospital
    Brussels, Belgium
    Not yet recruiting

Study contacts

  • Principal investigator: Sander Van Hoof, M.D. — University Hospital, Antwerp
  • Study coordinator: Sander Van Hoof, M.D.
  • Email: sander.vanhoof@uza.be
  • Phone: +3238212434

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.